UHealth's new Hypertension Clinic provides in-depth screening and personalized treatment for high blood pressure, the number one risk for heart attack and stroke, the leading causes of death in the United States. “About 45 percent of U.S. adults have high blood pressure, but many don’t realize it until they show up in the emergency room,” said Maria Carolina Delgado-Lelievre, M.D., assistant professor of medicine.
A Puerto Rican patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. On August 23, Julio Adorno Nieves, 23, became the first U.S. patient to receive new genes for his inherited, blinding condition in a worldwide Nightstar Therapeutics clinical trial.
In honor of his landmark research identifying the genes that cause deafness and its translation to patient care, Xue Zhong Liu, M.D., Ph.D., was recently honored with the Marian and Walter Hotchkiss Chair in Otolaryngology. Dr. Liu — an internationally renowned researcher, author, educator, and otolaryngologist — received the chair August 30 during a ceremony at the Lois Pope LIFE Center.
The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center, has received three important distinctions for the quality of its cancer registry data. For the 16th consecutive year, the Florida Cancer Data System (FCDS) has received Gold Certification from the North American Association of Central Cancer Registries.
A cross-departmental team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has received a five-year, $2 million grant from the National Cancer Institute to study ways to protect kidneys from radiation therapy. Specifically, the investigators will be seeking new information about the molecular mechanisms of radiation nephropathy.